Clinical Trial

OptiMized REsistaNt Starch in Inflammatory Bowel Disease: The MEND Trial

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the study is to determine if a plant-based resistant starch that is optimized for the individual will target the underlying cause of inflammatory bowel disease and restore a "healthier" gut microbiome in pediatric participants with inflammatory bowel disease.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2020-08-19; most recent amendment 2026-01-28.
Status change: Recruiting → Active, Not Recruiting 2023-12-19
Status change: Not Yet Recruiting → Recruiting 2021-03-07
Trial Details
NCT Number NCT04520594
Lead Sponsor Children's Hospital of Eastern Ontario
Conditions Crohn Disease, Ulcerative Colitis, Inflammatory Bowel Diseases
Enrollment 100 participants
Start Date 2021-03-03
Primary Completion 2024-11-05 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-29